TGFBI expression is associated with a better response to chemotherapy in NSCLC.
about
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapyCombining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.Systems analysis of a mouse xenograft model reveals annexin A1 as a regulator of gene expression in tumor stroma.Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression.MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.Gallotannin imposes S phase arrest in breast cancer cells and suppresses the growth of triple-negative tumors in vivo.Epigenetic regulation of inflammatory cytokines and associated genes in human malignanciesIdentification and characterization of unique tumoricidal genes in rat umbilical cord matrix stem cells.MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis.TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells.Release of TGFβig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression.TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis.Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cellsId-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapyTGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients.Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research.The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis.β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-β-induced expression in urothelial carcinoma.Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma.
P2860
Q26768521-EDE9909D-4BFC-47B2-AE98-483D0972C9E4Q30580198-16357DD6-E1AE-41B3-8D01-ECC55C29D341Q34450225-237695EE-585C-45E2-9EDD-F2CEE4D364ADQ34450477-7E433D24-CF96-471B-82EE-04A7A4406708Q34791957-D459B85C-F4E4-4E6B-A889-547FBE8F1BE2Q35128160-01B85FC3-BCC8-409D-A857-9AC3A1273CB2Q35178132-589F5A14-6868-48C7-95D4-64460DF7B8B7Q35456178-D5D775E5-0D80-492B-AD5C-064117DA3EFCQ35487297-7DC4F48B-1E28-4C8E-A4D7-F29840665E4AQ35653768-63B5A3E5-119A-4962-B068-8034153FDF67Q35768799-28F80C25-B10B-469B-B263-BC57C7B4CB72Q36110492-D5415963-24AF-462A-9B5F-65A7C4995545Q36202508-A13CDD19-C8BD-40EE-8F04-F5B05E3597ACQ36235795-12C37487-E400-4D03-A2C1-940EFD54CBBAQ36402018-BED04AD4-49E8-4BFF-B588-FA3F83D27366Q36560184-F9120524-4F1D-4211-B1C1-0540542D66C4Q37056992-DB613A4C-5926-4081-BB5B-3BEA41D43BE0Q37107027-4EFEF49B-69C7-4487-9B56-56E7DC49DEF5Q37650665-45EA2E31-85E9-4247-9F2B-47F8EB3ACBA9Q39014286-3FAFA2B5-1CF3-4E16-8588-545D23FDC886Q39095223-F3D0F7A6-0892-4F6B-A8BF-A1E9EC11E7B9Q39096525-0B22900D-7BC2-4911-8C18-81666F731BEAQ40786475-AE4DE7E8-B749-4997-B602-2ED2931B5B0BQ41212619-6653F432-6DA8-457B-BBD5-014EEF2ACF43Q43487532-5FCA4EA0-AF72-4497-A199-BC16A95AC7B3Q47222464-915AFF48-76B2-4EE5-B794-2010BE685823Q47756091-C8C4936E-FF0F-4AA7-90C8-3338DD0AC118Q55001674-55675A27-E50C-448F-822B-601EB577B6A7
P2860
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@en
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@nl
type
label
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@en
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@nl
prefLabel
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@en
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@nl
P2093
P2860
P50
P356
P1433
P1476
TGFBI expression is associated with a better response to chemotherapy in NSCLC.
@en
P2093
Ana Rouzaut
Elisabeth Salvo
Ignacio Gil-Bazo
María D Lozano
María J Pajares
P2860
P2888
P356
10.1186/1476-4598-9-130
P577
2010-05-28T00:00:00Z
P5875
P6179
1037947982